EN DE

RH Bophelo Limited (RHB) Fair Value & Analysis

Financial Services · ZA · Market cap 107M ZAC

RB RH Bophelo Limited RHB · JSE
PriceR1.65
Fair ValueR3.30
Upside+100.0%
Quality49/100
Watch RH Bophelo Limited for free, get notified when fair value or trend changes. Watch for free
Expensive Growth
Highly profitable · 34.8% net margin
Low debt · negative free cash flow
Mixed vs. peers (7/12)
Narrow moat 34/100
Evidence: High Range R2.48 – R4.13 Share as image

Fair value as of: Jul 16, 2026

From 8 valuation models · updated 25 days ago

Share price +21.2% over the past month.

Below-average quality, screening 100% undervalued on our models.

What matters now

  • The price is below even our cautious bear case (R2.48). The market is more pessimistic than our downside scenario.
  • Solid quality (49/100) at a price below fair value, the discount is the argument here, not the business quality.
  • For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

R5.55 R0.0083 Fair Value R3.30 Mar 2021 Jul 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 16, 2026.

How to read this chart

60‑month range R0.0083 – R5.55 · fair‑value band R2.48 – R4.13 · the R1.65 price screens below the R3.30 fair value. Dashed = 300-day average. As of Jul 16, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

RH Bophelo Limited (RHB) currently trades at R1.65, while our model-based Fair Value estimate is R3.30, implying the stock looks roughly 100.0% undervalued today. The Quality Score stands at 49/100 (below-average quality), in the Financial Services sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.

Over the trailing twelve months, RH Bophelo Limited generated revenue of 53.4M ZAR at a net margin of 34.8%. Revenue declined 84.5% year over year. It earns a return on equity of 1.7%. The stock trades on a trailing P/E of 5.7. Fundamentals as of Jul 16, 2026

Our scenario range runs from R2.48 (bear case) to R4.13 (bull case); at R1.65, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. For context, the median of 10 Financial Services peers we cover trades at -12% fair-value upside, at 100%, RHB screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Residual Income R10.74 R9.99 R6.72 76
Gordon GGM R2.16 R3.62 R4.69 70
P/E Multiple R4.74 R6.32 R7.89 63
All 8 models by family
Earnings-Based
Graham-Dodd R1.95 R13.61 R19.10 54
Lynch FV R5.01 R7.15 R9.30 50
Dividend Discount
Gordon GGM R2.16 R3.62 R4.69 70
DDM Multi-Stage R2.16 R3.43 R3.89 61
Multiples
P/E Multiple R4.74 R6.32 R7.89 63
P/B Multiple R3.66 R4.88 R6.10 55
Asset-Based
NCAV (Graham) R8.48 R11.36 R16.95 50
Economic Profit
Residual Income R10.74 R9.99 R6.72 76

Widest divergence: Asset-Based (R11.36) versus Dividend Discount (R3.43). Highest evidence: Residual Income (76).

Notify me when RHB reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) 53.4M ZAC
Revenue growth (YoY) -84.5%
Net margin 34.8%
Return on equity 1.7%
Free cash flow −16.5M ZAC FY2026
P/E ratio 5.7
More key figures
Operating margin -38.5%
EPS (TTM) R0.2900
EPS growth (YoY) -0.7%
Net debt 516K ZAC FY2026

Figures from reported company fundamentals · as of Jul 16, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 49/100

Of which business quality 47 · Market factors (momentum, volatility) 41

Profitability 29
Margins and returns on capital today
Quality Growth 40
Are margins and returns improving?
Cashflow 33
Earnings quality: real cash, not paper profit
Fin. Strength 45
Balance sheet, leverage, solvency risk
Investment 75
Disciplined investing over empire-building
Low Volatility 50
Calm price path (market factor)
Momentum 36
Price trend over the last 3–12 months (market factor)
52W Momentum 40
Distance to the 52-week high (market factor)
Net Issuance 82
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

RH Bophelo Limited, together with its subsdidiaries, invests in the healthcare and financial sector in South Africa. It is involved in investment of equity, quasi-equity, and equity related investments in operational infrastructure, health insurance, private hospital infrastructure, pharmaceuticals, retail and distribution, and healthcare technology.

Full company description

RH Bophelo Limited, together with its subsdidiaries, invests in the healthcare and financial sector in South Africa. It is involved in investment of equity, quasi-equity, and equity related investments in operational infrastructure, health insurance, private hospital infrastructure, pharmaceuticals, retail and distribution, and healthcare technology. The company was incorporated in 2016 and is based in Johannesburg, South Africa. RH Bophelo Limited operates as a subsidiary of Public Investment Corporation SOC Limited.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

RH Bophelo Limited reported revenue of R89.6M in FY2026 versus R31.8M in FY2022, a compound +29.6%/yr. Reported net income was R18.6M in FY2026, compounding −23.2%/yr from FY2022.

Growth Quality 62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Latest Revenue (FY 2026)
89.6M ZAR
Latest YoY
+124.9%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+31.1%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+43.4%
Avg. growth/yr (8Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+20.0%
Revenue +29.6%/yr
FY22 R31.8M
FY23 R39.8M
FY24 R41.3M
FY25 R39.8M
FY26 R89.6M
Net income −23.2%/yr
FY22 R53.5M
FY23 −R32.2M
FY24 R183M
FY25 R43.9M
FY26 R18.6M

Watch RHB: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "RH Bophelo Limited Fair Value". https://www.fairvalue-calculator.com/stock/RHB

Peer Group

Asset Management · 970 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 49 · Below median
Fair Value upside +100% · Top 25%
Return on equity (TTM) 2% · Below median
Return on assets 1% · Below median
Net margin (TTM) 35% · Above median
Operating margin (TTM) -38% · Bottom 25%
Revenue growth -85% · Bottom 25%

Valuation Multiples vs Asset Management median · lower = cheaper

P/E (TTM) 5.7× · Cheaper than 75% of peers
P/B 0.10× · Cheaper than 75% of peers
P/S (TTM) 2.00× · Cheaper than median
EV/EBITDA 2.9× · Cheaper than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 100 · sector 37
FUTURE 0 · sector 6
PAST 7 · sector 26
HEALTH 100 · sector 95
DIVIDEND 0 · sector 70

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Asset Management stocks, each showing price versus our Fair Value estimate (as of Jul 16, 2026).

Stock Price Fair Value vs Fair Value
Fondul Proprietatea SA FP $0.0420 $0.0800 +90%
BlackRock, Inc BLK $1,136 $465.75 -59%
Blackstone Inc BX $124.56 $16.35 -87%
Investor AB INVEB kr 423.70 kr 847.40 +100%
Brookfield Corporation BN C$62.45 C$10.12 -84%
KKR & Co KKR $100.94 $44.88 -56%
AB Industrivärden INDUA kr 532.50 kr 1,065 +100%
Jio Financial Services Limited JIOFIN ₹242.98 ₹40.19 -83%
Hedef Holding HEDEF 267.25 TRY 320.98 TRY +20%
Bajaj Holdings BAJAJHLDNG ₹10,398 ₹9,202 -12%

Compare RH Bophelo Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Financial Services stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is RH Bophelo Limited (RHB) overvalued or undervalued?
As of Jul 16, 2026, our model estimates a fair value of R3.30 versus a price of R1.65, about +100% (undervalued).
What is the fair value of RHB?
Our model-based fair value for RH Bophelo Limited is R3.30 (as of Jul 16, 2026), built from audited fundamentals. The current price is R1.65.
What is the quality score of RHB?
RH Bophelo Limited has a Quality Score of 49/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of RH Bophelo Limited (RHB)?
RH Bophelo Limited reported trailing-twelve-month revenue of about 53.4M ZAR (latest available figure, as of Jul 16, 2026).
What is the net profit margin of RHB?
The net profit margin of RH Bophelo Limited is about 34.8%, meaning it keeps roughly 34.8% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track RH Bophelo Limited and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.